知镜 Cognispect · 医学文献与研究工作台

Unfolded protein response pathway in neurodegenerative diseases: Genetic insights into the mechanisms linking UPR dysregulation to Tau pathology and therapeutic implications.

Babu S, LeSourd KS, Yuan SH.
Pharmacological research · 2026-10-29 · PMID 42956861

文献摘要

Endoplasmic reticulum (ER) stress activates a dynamic signaling network known as the unfolded protein response (UPR), which aims to reestablish cellular protein homeostasis and promote cell survival during stress. Dysregulated UPR signaling has been increasingly implicated in neurodegenerative diseases, many of which are characterized by tau hyperphosphorylation, misfolding, aggregation, and impaired clearance, contributing to neuronal dysfunction and degeneration. Genetic variations in UPR pathway components and their downstream effectors may influence the magnitude, duration, and cellular consequences of ER stress responses, thereby shaping disease susceptibility, progression, and therapeutic response. This review examines genetic variation within the UPR pathway and its relevance to the pathophysiology of tau-associated neurodegenerative diseases. By integrating evidence from genetic, cellular, and disease-model studies, we highlight how UPR dysregulation represents an important mechanistic interface linking genetic susceptibility with cellular stress responses, proteostasis disruption, and tau pathology. The article further explores UPR-focused therapeutic approaches, emphasizing how understanding genetic variation may provide insights into disease mechanisms and identify potential therapeutic targets. Building on these findings, we propose a framework in which UPR dysregulation is viewed not merely as a passive cellular response to neurodegeneration, but as a potential mechanistic determinant linking genetic risk to altered stress adaptation, proteostatic imbalance, and tau pathology. Within this framework, genetic variation in UPR components may contribute to distinct disease-relevant UPR states and influence therapeutic responsiveness. Integrating genetic variation with functional UPR signatures and treatment response may ultimately reveal disease-relevant therapeutic opportunities and inform the development of more precise UPR-targeted strategies for tau-associated neurodegenerative diseases.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。